Back to dashboard
All PlansAdministrativeMedium impact

Voluntary nationwide recall: Sucralfate

UPMC Health Plan·Gastroenterology, Internal Medicine, Family Medicine·Pharmacy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

VistaPharm LLC has issued a voluntary nationwide recall of one lot of Sucralfate Oral Suspension (1 g/10 mL) due to Bacillus cereus contamination. This anti-ulcer medication should not be dispensed or administered from the recalled lot.

Action Required

Action needed
Immediately: Clinical staff must check all Sucralfate Oral Suspension inventory to identify and quarantine any products from the recalled lot. Contact patients who may have received the recalled medication. Pharmacy staff should coordinate with suppliers for replacement products. Document any adverse events and report to appropriate authorities.